Clinical Trial: Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166211) titled 'Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)' on Sept. 03.

Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of CM512 in subjects with CSU.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Chronic Spontaneous Urticaria (CSU)

Intervention: BIOLOGICAL: CM512 injection

subcutaneous injection

DRUG: placebo

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Keymed Biosciences Co.Ltd

Disclaimer: Curated by HT ...